In the field of cancer research, RCTs are a cornerstone for evaluating the efficacy and safety of new treatments. The rigorous adherence to CONSORT guidelines ensures that trials provide transparent, complete, and accurate information. This is crucial for clinicians, researchers, and policymakers who rely on high-quality evidence to make informed decisions about cancer care.
